Participated · Series A · Aug 2026

Remepy develops Hybrid Drugs that integrate prescription medicines with personalized, AI-driven therapeutic apps to combine pharmacology with adaptive physical, cognitive, and behavioral interventions. The company partners with pharmaceutical firms to co-develop these drug–software combination products and recently announced a strategic collaboration with Merck KGaA. Remepy’s lead program, Hybridopa for Parkinson’s disease, produced encouraging Phase IIa results supported by peer‑reviewed publications and is being prepared for a global Phase III trial expected to begin in Q4 2026. The Series A financing and existing investor base have brought total capital raised to $62 million, providing funds to expand the company’s pipeline, platform, and pharmaceutical partnerships. Remepy positions its approach within emerging FDA frameworks for drug‑software combination products and aims to create new IP and lifecycle-management opportunities for partner drugs.

Participated · Seed · Jul 2026

Marquee provides an AI-driven scouting and recruitment platform used by football recruitment departments to find targets, read full player reports, build shortlists, shape shadow squads and compare preferred targets by position. Users reportedly stay in the product to conduct workflows end-to-end rather than merely running searches, with the platform informing decisions about whom to watch live. The company says feedback from sporting directors and technical evaluators highlights the depth and reliability of its reports. Marquee emphasizes enabling teams to finish the week further ahead while retaining human judgement. Following the seed raise, Marquee plans to accelerate building and expand the platform with the newly raised capital. No revenue, user counts, founding year or location details were provided in the announcement.

Participated · Seed · Dec 2025

Founded in July 2024, Medida has developed a computer-vision and artificial-intelligence platform that lets contractors capture millimeter-level measurements with a simple smartphone scan, eliminating the need for on-site surveyors. The system is already being used mainly for doors and windows and is now being extended to kitchens, flooring, and bathrooms. After just nine months in the U.S. market, the product is deployed across 35 states and is generating $3 million in annual recurring revenue. Management projects the company will reach profitability in the first quarter of 2026. Medida estimates that measurement errors and on-site visits cost U.S. suppliers hundreds of thousands of dollars annually, positioning its solution as a major cost and time saver in a $2.5 trillion renovation industry. The company employs 12 people and operates from offices in Tel Aviv and New York.

Participated · Seed · May 2025

Celery builds AI-driven audit agents that automate internal controls and financial monitoring for payroll, revenue, and expenses, requiring no software setup or system integration. The platform evolved from a payroll auditing tool into a broader financial oversight system used by dozens of U.S. healthcare organizations, including Ultimate Care. Celery reports reducing manual oversight by up to 91%, cutting payroll costs by 0.6% on average, and delivering 8x ROI; to date it has processed over 430,000 payslips, analyzed more than $550 million in payroll data, and helped prevent $2.3 million in losses. The company is SOC 2 certified, was founded in 2023, and is based in Tel Aviv, Israel. Celery plans to use new capital to expand go-to-market operations, accelerate product development, and launch audit agents focused on expense review, fraud detection, and fixed asset controls. It is also exploring channel partnerships with payroll providers and accounting platforms.

Participated · Seed · Apr 2025

TrialKit provides an AI-native legal discovery platform designed to help defense attorneys manage large volumes of digital evidence. Its features include automated organization and categorization that ingests and labels unstructured discovery and AI-powered search that converts and translates videos, PDFs, audio and other files into searchable text. The platform also offers entity extraction and cross-reference mapping to identify people, locations, and times across thousands of files, plus facial recognition for video review. An Interactive Workstation integrates tools for note-taking, fact mapping, and witness preparation so attorneys can analyze discovery and get case-ready in one secure workspace. TrialKit is used by more than 20 criminal defense firms and in public criminal defense cases across the U.S. The company intends to use the funds to expand operations and its development efforts; it is led by CEO Ariel Deshe.